XML 81 R32.htm IDEA: XBRL DOCUMENT

Segment Information (Tables)

9 Months Ended

Mar. 31, 2026

Schedule of results of operations and identifiable assets by industry segment

The following tables present our results of operations and identifiable assets by our three industry segments, along with amounts for Corporate/Eliminations, which are reconciled to consolidated amounts (in thousands):


		Three Months Ended March 31, 2025
					Optoelectronics
					and
		Security			Manufacturing			Healthcare			Corporate/
		Division			Division			Division			Eliminations			Consolidated
Revenues (1):
External customer revenue		$	314,908		$	85,724		$	43,722		$	—		$	444,354
Revenue between segments			—			15,136			—			(15,136)			—
Total revenues			314,908			100,860			43,722			(15,136)			444,354
Cost of goods sold			209,498			77,926			21,663			(15,024)			294,063
Selling, general and administrative expenses			39,499			7,942			15,827			9,981			73,249
Research and development expenses			13,003			1,270			4,297			—			18,570
Segment income (loss) from operations			52,908			13,722			1,935			(10,093)			58,472
Impairment, restructuring and other charges			1,403			72			627			153			2,255
Income (loss) from operations		$	51,505		$	13,650		$	1,308		$	(10,246)		$	56,217
Capital expenditures		$	1,787		$	1,234		$	132		$	1,365		$	4,518
Depreciation and amortization		$	7,262		$	1,629		$	1,269		$	407		$	10,567

(1)	For the three months ended March 31, 2025, one customer in the Security division accounted for 14% of the Company’s consolidated net revenues.


		Three Months Ended March 31, 2026
					Optoelectronics
					and
		Security			Manufacturing			Healthcare			Corporate/
		Division			Division			Division			Eliminations			Consolidated
Revenues (2):
External customer revenue		$	319,263		$	93,282		$	40,701		$	—		$	453,246
Revenue between segments			—			17,716			—			(17,716)			—
Total revenues			319,263			110,998			40,701			(17,716)			453,246
Cost of goods sold			213,141			87,219			20,167			(17,605)			302,922
Selling, general and administrative expenses			37,172			7,884			15,637			10,794			71,487
Research and development expenses			13,546			1,282			4,627			—			19,455
Segment income (loss) from operations			55,404			14,613			270			(10,905)			59,382
Impairment, restructuring and other charges			1,433			—			2,636			2,099			6,168
Income (loss) from operations		$	53,971		$	14,613		$	(2,366)		$	(13,004)		$	53,214
Capital expenditures		$	5,681		$	834		$	690		$	354		$	7,559
Depreciation and amortization		$	6,217		$	1,790		$	1,040		$	475		$	9,522

(2)	For the three months ended March 31, 2026, no customer accounted for 10% or more of the Company’s consolidated net revenues.


	Nine Months Ended March 31, 2025
			Optoelectronics
			and
	Security		Manufacturing		Healthcare		Corporate/
	Division		Division		Division		Eliminations		Consolidated
Revenues (3):
External customer revenue	$	829,209	$	253,294	$	125,678	$	—	$	1,208,181
Revenue between segments		—		46,104		—		(46,104)		—
Total revenues		829,209		299,398		125,678		(46,104)		1,208,181
Cost of goods sold		536,651		233,921		63,801		(45,136)		789,237
Selling, general and administrative expenses		118,121		24,443		44,683		28,947		216,194
Research and development expenses		38,141		3,874		12,585		—		54,600
Segment income (loss) from operations		136,296		37,160		4,609		(29,915)		148,150
Impairment, restructuring and other charges		1,882		619		779		368		3,648
Income (loss) from operations	$	134,414	$	36,541	$	3,830	$	(30,283)	$	144,502
Capital expenditures	$	10,945	$	3,299	$	690	$	2,779	$	17,713
Depreciation and amortization	$	22,001	$	5,513	$	3,945	$	1,205	$	32,664

(3)	For the nine months ended March 31, 2025, one customer in the Security division accounted for 13% of the Company’s consolidated net revenues.


	Nine Months Ended March 31, 2026
			Optoelectronics
			and
	Security		Manufacturing		Healthcare		Corporate/
	Division		Division		Division		Eliminations		Consolidated
Revenues (4):
External customer revenue	$	908,216	$	275,732	$	117,978	$	—	$	1,301,926
Revenue between segments		—		57,279		—		(57,279)		—
Total revenues		908,216		333,011		117,978		(57,279)		1,301,926
Cost of goods sold		612,645		262,087		58,048		(55,992)		876,788
Selling, general and administrative expenses		111,339		25,596		42,480		29,228		208,643
Research and development expenses		41,104		3,795		14,742		—		59,641
Segment income (loss) from operations		143,128		41,533		2,708		(30,515)		156,854
Impairment, restructuring and other charges		5,087		261		4,325		2,099		11,772
Income (loss) from operations	$	138,041	$	41,272	$	(1,617)	$	(32,614)	$	145,082
Capital expenditures	$	13,432	$	4,228	$	2,226	$	1,386	$	21,272
Depreciation and amortization	$	19,466	$	5,191	$	3,277	$	1,454	$	29,388

(4)	For the nine months ended March 31, 2026, no customer accounted for 10% or more of the Company’s consolidated net revenues.


		June 30,			March 31,
		2025			2026
Assets (1) —by Segment:
Security division		$	1,608,985		$	1,676,393
Optoelectronics and Manufacturing division			300,405			298,898
Healthcare division			270,428			284,204
Corporate/Eliminations (2)			61,439			294,936
Total		$	2,241,257		$	2,554,431

(1)As of June 30, 2025 and March 31, 2026, one customer in the Security division accounted for 42% and 40% of the Company’s accounts receivable, net, respectively.

(2)Eliminations in assets reflect the amount of inter-segment profits in inventory and inter-segment ROU assets under ASC 842 as of the balance sheet date. Such inter-segment profit in inventory will be realized when the associated inventory is shipped to the external customers of the Security and Healthcare divisions.